Which State Medicaid Programs Cover GLP-1s for Weight Loss & How Much Are They Spending
These compounds differ in how they work, what they target, how long they stay active in the body, and what evidence exists to support their use
Rights and permissions About this article Cite this article Victorino, D.B., Nejm, M., Guimares-Marques, M
The activation of different metabolic pathways during the various stages of the efferocytic process, as well as the products generated during the degradation of apoptotic cells, necessitates an adaptation of lipid, carbohydrate, and amino acid metabolism, enabling the integrated functioning of these pathways to sustain the phenotype and activate immune cells
Clinical Evidence Summary Study Type: Retrospective analysis (not a randomized controlled trial) Participants: 1,131 program completers with BMI 30 Duration: 52-68 weeks Primary Outcome: 19.5% average body weight reduction at 52 weeks Medication: 95.4% compounded semaglutide, 4.6% branded semaglutide Control Group: None Funding/Authors: Ivm Health-affiliated authors (conflict of interest disclosed) Publication: Obesity Pillars , 2025 (PubMed indexed, peer-reviewed) Key Limitation: Self-selected completers
All it takes is a smartphone, tablet, or computer to connect with one of our semaglutide specialists
